BDBM168813 US9079866, 212::US9745328, Compound 212::US9884878, Compound 212

SMILES: CN1CCN(CC1)S(=O)(=O)c1cc(ccc1-c1ccc(c(F)c1)-c1cnc(N)cn1)C(F)(F)F

InChI Key: InChIKey=WDJBSRFZVCSLNJ-UHFFFAOYSA-N

Data: 3 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 168813   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
5-lipoxygenase/FLAP (Homo sapiens (Human))	BDBM168813 (US9079866, 212 | US9745328, Compound 212 | US98848...) Show SMILES CN1CCN(CC1)S(=O)(=O)c1cc(ccc1-c1ccc(c(F)c1)-c1cnc(N)cn1)C(F)(F)F Show InChI InChI=1S/C22H21F4N5O2S/c1-30-6-8-31(9-7-30)34(32,33)20-11-15(22(24,25)26)3-5-16(20)14-2-4-17(18(23)10-14)19-12-29-21(27)13-28-19/h2-5,10-13H,6-9H2,1H3,(H2,27,29)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
JANSSEN PHARMACEUTICA NV US Patent					Assay Description The assay below is used to test the modulatory activity of compounds against FLAP. Human and mouse FLAP-encoding DNA was amplified by polymerase chai...				US Patent US9079866 (2015) BindingDB Entry DOI: 10.7270/Q2FF3R3Q
					More data for this Ligand-Target Pair
Flap endonuclease 1 (Homo sapiens (Human))	BDBM168813 (US9079866, 212 | US9745328, Compound 212 | US98848...) Show SMILES CN1CCN(CC1)S(=O)(=O)c1cc(ccc1-c1ccc(c(F)c1)-c1cnc(N)cn1)C(F)(F)F Show InChI InChI=1S/C22H21F4N5O2S/c1-30-6-8-31(9-7-30)34(32,33)20-11-15(22(24,25)26)3-5-16(20)14-2-4-17(18(23)10-14)19-12-29-21(27)13-28-19/h2-5,10-13H,6-9H2,1H3,(H2,27,29)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description The FLAP binding assay is performed in HTRF format (homogeneous time resolved fluorescence). FLAP-containing membranes (1 μg/well final for huma...				US Patent US9745328 (2017) BindingDB Entry DOI: 10.7270/Q2H13446
					More data for this Ligand-Target Pair
5-lipoxygenase/FLAP (Homo sapiens (Human))	BDBM168813 (US9079866, 212 | US9745328, Compound 212 | US98848...) Show SMILES CN1CCN(CC1)S(=O)(=O)c1cc(ccc1-c1ccc(c(F)c1)-c1cnc(N)cn1)C(F)(F)F Show InChI InChI=1S/C22H21F4N5O2S/c1-30-6-8-31(9-7-30)34(32,33)20-11-15(22(24,25)26)3-5-16(20)14-2-4-17(18(23)10-14)19-12-29-21(27)13-28-19/h2-5,10-13H,6-9H2,1H3,(H2,27,29)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
JANSSEN PHARMACEUTICA NV US Patent					Assay Description The assay below is used to test the modulatory activity of compounds against FLAP. Human and mouse FLAP-encoding DNA was amplified by polymerase chai...				US Patent US9884878 (2018) BindingDB Entry DOI: 10.7270/Q2R78H8P
					More data for this Ligand-Target Pair